Expression and Prognostic Significance of PDIA3 in Cervical Cancer

Table 2

Relationship between PDIA3 protein expression and clinicopathological characteristics of cervical cancer [n (%)].

Clinicopathological parameters	n	PDIA3 expression [n (%)]		-value
		Low	High
Age (years)
<50	76	26 (34.2)	50 (65.8)	0.1299
≥50	35	18 (51.4)	17 (48.6)
Recurrence
None	74	31 (41.9)	43 (58.1)	0.6311
Yes	37	13 (35.1)	24 (64.9)
Pathological type
Squamous carcinoma	85	36 (42.4)	49 (57.6)	0.0004
Adenocarcinoma	3	0 (0.0)	3 (100.0)
Adenosquamous carcinoma	5	5 (100.0)	0 (0.0)
Local squamous cell carcinoma	17	2 (11.8)	15 (88.2)
Mixed adenocarcinoma	1	0 (100.0)	1 (0.0)
T stage
T1	62	22 (35.5)	40 (64.5)	0.4749
T2	29	12 (41.4)	17 (58.6)
T3	19	10 (52.6)	9 (47.4)
T4	1	0 (0.0)	1 (100.0)
N stage
N0	92	34 (37.0)	58 (63.0)	0.3105
N1	19	10 (52.6)	9 (47.4)